In vivo studies are crucial to the discovery and development of novel drugs and are conducted for proof-of-concept validation, FDA applications and to support clinical trials. Appropriate study design, data analyses and interpretation are essential …
As the Pharmaceutical sector boosts its interactions with regulatory agencies using R programming as one key instrument for drug development submissions, we face a dilemma that several members of statistics and statistical programming teams are not …
Next-generation sequencing (NGS), phage display technology and high throughput capacities enables biologists in drug discovery to characterize antibodies (Abs) based on their HCDR3 sequences and further group them into families before moving to …